Responses
Emerging technologies, pharmacology and therapeutics
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study
Compose a Response to This Article
Other responses
No responses have been published for this article.